No Data
B.Riley Financial Upgrades Cognition Therapeutics(CGTX.US) to Buy Rating, Raises Target Price to $1.5
Analysts Offer Insights on Healthcare Companies: Cognition Therapeutics (CGTX), Roche Holding AG (OtherRHHVF) and Incyte (INCY)
B. Riley Upgrades Cognition Therapeutics to Buy on Lewy Bodies Data
B. Riley Upgrades Cognition Therapeutics to Buy From Neutral, Lifts PT to $1.50 From $1
Cognition Therapeutics Is Maintained at Buy by Chardan Capital
Cognition Therapeutics Price Target Maintained With a $11.00/Share by Chardan Capital
No Data
In the dream ~ shorting you
Gan John : What time will it be released?
_God_ : HAHAHAHAHAHA!!!!!